Single dose of injectable dye could help make melanoma history
Washington: Researchers are investigating whether an injectable dye known as PV-10 is capable of shrinking tumours and reducing the spread of cancer.
According to the new study at Moffitt Cancer Center, PV-10 is a solution developed from Rose Bengal, a water-soluble dye commonly used to stain damaged cells in the eye.
Early clinical trials show PV-10 can boost immune response in melanoma tumors, as well as the blood stream.
Shari Pilon-Thomas, Ph.D., assistant member of Moffitt`s Immunology Program, said that various injection therapies for melanoma have been examined over the past 40 years, but few have shown the promising results that they are currently witnessing with PV-10.
In the initial study, researchers injected a single dose of PV-10 into mice with melanoma.
The result was a significant reduction in the skin cancer lesions, as well as a sizable reduction in melanoma tumors that had spread to the lungs.
The researchers said the dye solution appeared to produce a robust anti-tumor immune response and may be safer than existing immunological agents.
The study appears in PLOS ONE, an open-access, peer-reviewed online journal.
More from India
More from World
More from Sports
More from Entertaiment
- J&K: Suspected Pakistani spy arrested in Samba district
- DNA: Reporting on war against ISIS in Mosul
- Kerala: Medical college prohibits girls from wearing jeans, noisy ornaments
- Ramgopal Yadav writes letter to SP party workers after Akhilesh Yadav sacked Shivpal Yadav
- DNA: Analysing the derogatory remarks made by Chinese Newspaper on Indians
- India vs New Zealand, 3rd ODI: As it happened...
- Samajwadi Party feud intensifies: Shivpal Yadav sacked, Ramgopal Yadav expelled - As it happened
- 'Ae Dil Hai Mushkil' row: Raj Thackeray says Rs 5 crore 'penance' for signing Pakistani artistes
- Kerala dress code row: 'Why not 'mundus' for men, if 'sarees' for women'
- PM Narendra Modi warns of 'surgical strikes' against black money, corruption